These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23178094)

  • 1. [Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): review of the Cancer Committee of the French Association of Urology].
    Neuzillet Y; Rouprêt M; Wallerand H; Pignot G; Larré S; Irani J; Davin JL; Moreau JL; Soulié M; Pfister C;
    Prog Urol; 2012 Dec; 22(16):989-98. PubMed ID: 23178094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guidelines for good practice of intravesical instillations of BCG and mitomycin C from the French national cancer committee (CC-AFU) for non-muscle invasive bladder cancer].
    Rouprêt M; Neuzillet Y; Larré S; Pignot G; Coloby P; Rébillard X; Mongiat-Artus P; Chartier-Kastler E; Soulié M; Pfister C;
    Prog Urol; 2012 Nov; 22(15):920-31. PubMed ID: 23102014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of non-muscle invasive bladder tumours by instillations of mitomycin C and BCG: a survey on French urologists by the French Urological Association].
    Descazeaud A; Mignard JP; Davin JL; Irani J
    Prog Urol; 2009 Oct; 19(9):624-31. PubMed ID: 19800553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and management of severe adverse events occurring during BCG therapy for non-muscle invasive bladder cancer (NMIBC)].
    Neuzillet Y; Rouprêt M; Larré S; Irani J; Davin JL; Moreau JL; Pfister C
    Presse Med; 2013; 42(7-8):1100-8. PubMed ID: 23453501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey.
    Nielsen ME; Smith AB; Pruthi RS; Guzzo TJ; Amiel G; Shore N; Lotan Y
    BJU Int; 2012 Oct; 110(7):967-72. PubMed ID: 22487336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines from the cancer (CC-AFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG].
    Audenet F; Sotto A; Roumiguié M; Allory Y; Andrejak C; Leon P; Loriot Y; Masson-Lecomte A; Pradère B; Seisen T; Traxer O; Xylinas E; Bruyère F; Roupret M; Saint F; Neuzillet Y
    Prog Urol; 2022 Mar; 32(3):165-176. PubMed ID: 35125314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer.
    Chen CH; Yang HJ; Shun CT; Huang CY; Huang KH; Yu HJ; Pu YS
    Urol Oncol; 2012; 30(4):421-7. PubMed ID: 20870427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary leukocytes as a new prognostic marker of therapeutic response and of adverse effects associated with the maintenance treatment with endovesical BCG, for the prophylaxis of superficial bladder tumors].
    Saint F; Irani J; Salomon L; Legrand P; Abbou CC; Chopin D
    Prog Urol; 2001 Dec; 11(6):1242-50. PubMed ID: 11859659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy.
    Menke JJ; Heins JR
    Ann Pharmacother; 2000 Apr; 34(4):479-82. PubMed ID: 10772435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elevation of total PSA after intravesical BCG instillations: granulomatous prostatitis or prostatic adenocarcinoma?].
    Blah M; Gobet F; Dugardin F; Catovic B; Loisel F; Pfister C
    Prog Urol; 2008 Feb; 18(2):108-13. PubMed ID: 18396238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylactic effect of inductive intravesical instillation of Bacillus Calmette-Guerin on postoperative recurrence of bladder cancer].
    Yi SH; Ye G; Wang XW; Jin HS; Zhang YN; Yan ZL
    Ai Zheng; 2008 Nov; 27(11):1208-11. PubMed ID: 19000455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Granulomatous prostatitis as a complication of BCG intravesical instillation. Report of a case].
    Luján Galán M; Sánchez Sánchez E; Páez Borda A; Berenguer Sánchez A
    Arch Esp Urol; 1996 Nov; 49(9):979-81. PubMed ID: 9133300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term administration of prulifloxacin in patients with nonmuscle-invasive bladder cancer: an effective option for the prevention of bacillus Calmette-Guérin-induced toxicity?
    Damiano R; De Sio M; Quarto G; Di Lorenzo G; Perdonà S; Palumbo IM; Azzarito G; Giugliano F; Autorino R
    BJU Int; 2009 Sep; 104(5):633-9. PubMed ID: 19298412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer.
    Matsumoto K; Kikuchi E; Shirakawa H; Hayakawa N; Tanaka N; Ninomiya A; Miyajima A; Nakamura S; Oya M
    BJU Int; 2012 Dec; 110(11 Pt B):E508-13. PubMed ID: 22574662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study.
    Ji N; Mukherjee N; Reyes RM; Gelfond J; Javors M; Meeks JJ; McConkey DJ; Shu ZJ; Ramamurthy C; Dennett R; Curiel TJ; Svatek RS
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cases of bacillus Calmette-Guerin-induced granulomatous prostatitis and prostatic stromal invasion of the bladder carcinoma in situ, showing similar clinical findings].
    Okusa H; Irie A; Chin I; Baba S; Mitomi H; Shitara T
    Hinyokika Kiyo; 2003 Sep; 49(9):555-7. PubMed ID: 14598697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ BCG-immunotherapy and bladder cancer].
    Rischmann P
    Prog Urol; 2008 May; 18 Suppl 5():S93. PubMed ID: 18585633
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravesical BCG-therapy: comparison of side effects of Connaught (Toronto) and Pasteur (Paris) strains].
    Champetier D; Valignat C; Lopez JG; Ruffion A; Devonec M; Perrin P
    Prog Urol; 2000 Sep; 10(4):542-7. PubMed ID: 11064894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BCG infection of the glans penis after intravesical BCG therapy].
    Michelet N; Spenatto N; Viraben R; Cuny JF; Mazet J; Trechot P; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2008; 135(6-7):479-83. PubMed ID: 18598797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study.
    Colombel M; Saint F; Chopin D; Malavaud B; Nicolas L; Rischmann P
    J Urol; 2006 Sep; 176(3):935-9. PubMed ID: 16890660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.